Last Price
379.40
Today's Change
+1.40 (0.37%)
Day's Change
374.10 - 379.50
Trading Volume
9,416,834
Market Cap
34 Billion
Shares Outstanding
9 Billion
Avg Volume
22,651,879
Avg Price (50 Days)
376.46
Avg Price (200 Days)
362.38
PE Ratio
29.18
EPS
0.13
Earnings Announcement
27-Feb-2025
Previous Close
378.00
Open
374.70
Day's Range
374.1 - 379.5
Year Range
308.37 - 400.649
Trading Volume
9,416,834
1 Day Change
0.37%
5 Day Change
1.20%
1 Month Change
-0.50%
3 Month Change
4.43%
6 Month Change
1.55%
Ytd Change
0.16%
1 Year Change
17.46%
3 Year Change
23.04%
5 Year Change
23.04%
10 Year Change
23.04%
Max Change
23.04%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Description:
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.